Insider plans 10,000-share sale in CRMD (NASDAQ: CRMD)

Rhea-AI Filing Summary

A person associated with CRMD has filed a notice to sell common stock under Rule 144. The filing shows a planned sale of 10,000 common shares through Merrill Lynch, with an aggregate market value of 68,502, on or about 01/21/2026 on the NASDAQ. The issuer had 78,789,045 shares of common stock outstanding. The seller acquired these 10,000 shares on 01/17/2026 via stock plan activity.

Over the prior three months, the same seller completed additional sales of common stock, including 34,000 shares for 407,030 on 12/09/2025, 46,657 shares for 465,169 on 12/02/2025, and 26,343 shares for 260,805 on 11/24/2025. This Form 144 is a notice of intent and does not by itself confirm that the planned shares have been sold.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/21/2026 - 04:42 PM Learn about SEC filing dates

FAQ

What does the CRMD Form 144 filing disclose?

The Form 144 discloses a planned sale of 10,000 common shares of CRMD stock through Merrill Lynch, with an aggregate market value of 68,502, to be sold on or about 01/21/2026 on the NASDAQ.

How many CRMD shares are planned to be sold under this Form 144?

The notice covers an intended sale of 10,000 common shares of CRMD, with an aggregate market value of 68,502 as shown in the filing.

When and how were the CRMD shares to be sold acquired?

The 10,000 common shares to be sold were acquired on 01/17/2026 through stock plan activity from the issuer, with the same date listed as the date of payment.

How many CRMD shares are outstanding according to this notice?

The filing states that there are 78,789,045 common shares of CRMD outstanding.

What CRMD stock sales occurred in the past 3 months by this seller?

In the past three months, the seller reported CRMD common stock sales of 34,000 shares for 407,030 on 12/09/2025, 46,657 shares for 465,169 on 12/02/2025, and 26,343 shares for 260,805 on 11/24/2025.

What is the purpose of a Rule 144 filing for CRMD stock?

A Rule 144 notice gives advance disclosure of an insider’s or affiliate’s intended sale of restricted or controlled CRMD shares, including the number of shares, market value, broker, and recent sales history.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 1800 K ST NW Suite 800 Washington DC 20006	10000	68502	78789045	01/21/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/17/2026	Stock Plan Activity	Issuer			10000	01/17/2026	n/a

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Janet Dillione 300 Connell Drive Suite 4200 Berkeley Heights NJ 07922	Common	12/09/2025	34000	407030
Janet Dillione 300 Connell Drive Suite 4200 Berkeley Heights NJ 07922	Common	12/02/2025	46657	465169
Janet Dillione 300 Connell Drive Suite 4200 Berkeley Heights NJ 07922	Common	11/24/2025	26343	260805

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)